GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Journal of Neuroinflammation, Springer Science and Business Media LLC, Vol. 17, No. 1 ( 2020-12)
    Abstract: In vivo assessment of neuroinflammation by 18-kDa translocator protein positron-emission-tomography (TSPO-PET) ligands receives growing interest in preclinical and clinical research of neurodegenerative disorders. Higher TSPO-PET binding as a surrogate for microglial activation in females has been reported for cognitively normal humans, but such effects have not yet been evaluated in rodent models of neurodegeneration and their controls. Thus, we aimed to investigate the impact of sex on microglial activation in amyloid and tau mouse models and wild-type controls. Methods TSPO-PET ( 18 F-GE-180) data of C57Bl/6 (wild-type), App NL-G-F (β-amyloid model), and P301S (tau model) mice was assessed longitudinally between 2 and 12 months of age. The App NL-G-F group also underwent longitudinal β-amyloid-PET imaging (Aβ-PET; 18 F-florbetaben). PET results were confirmed and validated by immunohistochemical investigation of microglial (Iba-1, CD68), astrocytic (GFAP), and tau (AT8) markers. Findings in cerebral cortex were compared by sex using linear mixed models for PET data and analysis of variance for immunohistochemistry. Results Wild-type mice showed an increased TSPO-PET signal over time (female +23%, male +4%), with a significant sex × age interaction ( T = − 4.171, p   〈  0.001). The Aβ model App NL-G-F mice also showed a significant sex × age interaction ( T = − 2.953, p  = 0.0048), where cortical TSPO-PET values increased by 31% in female App NL-G-F mice, versus only 6% in the male mice group from 2.5 to 10 months of age. Immunohistochemistry for the microglial markers Iba-1 and CD68 confirmed the TSPO-PET findings in male and female mice aged 10 months. Aβ-PET in the same App NL-G-F mice indicated no significant sex × age interaction ( T = 0.425, p  = 0.673). The P301S tau model showed strong cortical increases of TSPO-PET from 2 to 8.5 months of age (female + 32%, male + 36%), without any significant sex × age interaction ( T = − 0.671, p  = 0.504), and no sex differences in Iba-1, CD68, or AT8 immunohistochemistry. Conclusion Female mice indicate sex-dependent microglia activation in aging and in response to amyloidosis but not in response to tau pathology. This calls for consideration of sex difference in TSPO-PET studies of microglial activation in mouse models of neurodegeneration and by extension in human studies.
    Type of Medium: Online Resource
    ISSN: 1742-2094
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 2156455-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Alzheimer's & Dementia, Wiley, Vol. 16, No. S4 ( 2020-12)
    Abstract: In vivo assessment of neuroinflammation by 18 kDa translocator protein positron‐emission‐tomography (TSPO‐PET) ligands receives growing interest in preclinical and clinical research of neurodegenerative disorders. Higher TSPO expression in females has been reported for cognitively normal humans, but such effects have not yet been evaluated in rodent models of neurodegeneration and their controls. Thus, we aimed to investigate the impact of sex on TSPO expression in amyloid and tau mouse models and wild‐type (WT). Method Longitudinal 18F‐GE‐180 TSPO‐PET ( 18 F‐GE180) data of App NL‐G‐F (amyloid model), P301S (tau model) and C57Bl/6 (WT) mice were evaluated between two and twelve months of age. App NL‐G‐F received additional longitudinal amyloid‐PET (Aβ‐PET; 18 F‐florbetaben). Immunohistochemistry also served for validation of microglial (Iba1, CD68) and tau (AT8) markers at the terminal time point. PET and immunohistochemistry were quantified in cortical regions and compared by linear mixed models (PET) and analysis of variance (immunohistochemistry) between male and female mice. Result The amyloid model App NL‐G‐F revealed a distinct cortical increase of TSPO‐PET values from 2.5 to 10 months in female mice (+31%), whereas male mice only increased slightly (+6%). The linear mixed model indicated a significant sex x time interaction (T=‐2.953, b/SE=‐0.011/0.004, p=0.0048, Figure 1A), validated by Iba1 and CD68 immunohistochemistry (Figure 2). Aβ‐PET values in the same App NL‐G‐F mice indicated no significant time x sex interaction (T=0.425, b/SE=0.001/0.003, p=0.673, Figure 3). The P301S tau model showed strong cortical increases of TSPO‐PET from 2 to 8.5 months of age (female: +32%, male: +36%) but no significant sex x time interaction (T=‐0.671, b/SE=‐0.003/0.005, p=0.504, Figure 1B) and no differences in Iba1, CD68 or AT8 were observed. TSPO‐PET values in WT mice indicated an increase with time (female: +23%, male +4%) and a significant time x sex interaction was found (T=‐4.171, b/SE=‐0.009/0.002, p 〈 0.001, Figure 1C). Conclusion Female mice indicate a sex dependent elevation of glial activation in response to amyloidosis but not to tau pathology which could be related to differences in sex dependency of microglial activation pathways in presence of both proteins. Sex requires attention when microglia activation is evaluated in mouse models of Alzheimer’s disease and requires detailed studies in human disease.
    Type of Medium: Online Resource
    ISSN: 1552-5260 , 1552-5279
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2201940-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Movement Disorders, Wiley, Vol. 36, No. 4 ( 2021-04), p. 883-894
    Abstract: Neuroinflammation has received growing interest as a therapeutic target in neurodegenerative disorders, including 4‐repeat tauopathies. Objectives The aim of this cross‐sectional study was to investigate 18 kDa translocator protein positron emission tomography (PET) as a biomarker for microglial activation in the 4‐repeat tauopathies corticobasal degeneration and progressive supranuclear palsy. Methods Specific binding of the 18 kDa translocator protein tracer 18 F‐GE‐180 was determined by serial PET during pharmacological depletion of microglia in a 4‐repeat tau mouse model. The 18 kDa translocator protein PET was performed in 30 patients with corticobasal syndrome (68 ± 9 years, 16 women) and 14 patients with progressive supranuclear palsy (69 ± 9 years, 8 women), and 13 control subjects (70 ± 7 years, 7 women). Group comparisons and associations with parameters of disease progression were assessed by region‐based and voxel‐wise analyses. Results Tracer binding was significantly reduced after pharmacological depletion of microglia in 4‐repeat tau mice. Elevated 18 kDa translocator protein labeling was observed in the subcortical brain areas of patients with corticobasal syndrome and progressive supranuclear palsy when compared with controls and was most pronounced in the globus pallidus internus, whereas only patients with corticobasal syndrome showed additionally elevated tracer binding in motor and supplemental motor areas. The 18 kDa translocator protein labeling was not correlated with parameters of disease progression in corticobasal syndrome and progressive supranuclear palsy but allowed sensitive detection in patients with 4‐repeat tauopathies by a multiregion classifier. Conclusions Our data indicate that 18 F‐GE‐180 PET detects microglial activation in the brain of patients with 4‐repeat tauopathy, fitting to predilection sites of the phenotype. The 18 kDa translocator protein PET has a potential for monitoring neuroinflammation in 4‐repeat tauopathies. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
    Type of Medium: Online Resource
    ISSN: 0885-3185 , 1531-8257
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2041249-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...